BENJAMIN CAMPOS: Open Payments
NPI 1134794688 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,233 in 189 payments from 31 companies in 2025. Trend: 2023 $3,013 · 2024 $3,113 · 2025 $4,233
Food & beverage: $3,463Speaker / faculty: $770
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 24 | $1,269 |
| Novo Nordisk Inc | 17 | $427 |
| Bayer Healthcare Pharmaceuticals Inc. | 23 | $402 |
| ABBVIE INC. | 25 | $286 |
| Xeris Pharmaceuticals, Inc. | 13 | $232 |
| Lilly USA, LLC | 13 | $172 |
| PFIZER INC. | 10 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Axsome Therapeutics, Inc. | 4 | $87 |
Products named: Korlym, Kerendia, Ozempic, VRAYLAR, NURTEC ODT, RECORLEV, CAPLYTA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
